Anika Therapeutics reports second-quarter 2014 financial results
Anika Therapeutics reported net income for the 2014 second quarter was $9.3 million, or $0.60 per diluted share, versus $5.9 million, or $0.40 per diluted share, in the same 2013 quarter. Total revenue for the 2014 second quarter was $26.3 million versus $20.8 million in the second quarter of 2013. July 30, 2014